DK1334105T3 - Fremgangsmåde til fremstilling af krystallinsk N-formimidoylthienamycinmonohydrat (imipenemmonohydrat) - Google Patents

Fremgangsmåde til fremstilling af krystallinsk N-formimidoylthienamycinmonohydrat (imipenemmonohydrat)

Info

Publication number
DK1334105T3
DK1334105T3 DK01980805T DK01980805T DK1334105T3 DK 1334105 T3 DK1334105 T3 DK 1334105T3 DK 01980805 T DK01980805 T DK 01980805T DK 01980805 T DK01980805 T DK 01980805T DK 1334105 T3 DK1334105 T3 DK 1334105T3
Authority
DK
Denmark
Prior art keywords
monohydrate
crystalline
preparation
formimidoylthienamycin
imipenem
Prior art date
Application number
DK01980805T
Other languages
Danish (da)
English (en)
Inventor
Yatendra Kumar
Neera Tewari
Ram Chander Aryan
Bishwa Prakash Rai
Seema Ahuja
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11097114&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1334105(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Application granted granted Critical
Publication of DK1334105T3 publication Critical patent/DK1334105T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK01980805T 2000-11-03 2001-11-05 Fremgangsmåde til fremstilling af krystallinsk N-formimidoylthienamycinmonohydrat (imipenemmonohydrat) DK1334105T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN983DE2000 IN191798B (enExample) 2000-11-03 2000-11-03

Publications (1)

Publication Number Publication Date
DK1334105T3 true DK1334105T3 (da) 2006-08-14

Family

ID=11097114

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01980805T DK1334105T3 (da) 2000-11-03 2001-11-05 Fremgangsmåde til fremstilling af krystallinsk N-formimidoylthienamycinmonohydrat (imipenemmonohydrat)

Country Status (19)

Country Link
US (1) US7078534B2 (enExample)
EP (1) EP1334105B1 (enExample)
JP (1) JP2004525084A (enExample)
KR (1) KR20030059812A (enExample)
CN (1) CN100445284C (enExample)
AT (1) ATE322495T1 (enExample)
AU (1) AU2002212591A1 (enExample)
BG (1) BG107852A (enExample)
CA (1) CA2427762C (enExample)
DE (1) DE60118593D1 (enExample)
DK (1) DK1334105T3 (enExample)
EA (1) EA006442B1 (enExample)
EE (1) EE200300206A (enExample)
ES (1) ES2261494T3 (enExample)
IN (1) IN191798B (enExample)
MX (1) MXPA03003916A (enExample)
PT (1) PT1334105E (enExample)
WO (1) WO2002036594A1 (enExample)
ZA (1) ZA200303338B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ529625A (en) * 2001-05-18 2006-02-24 Ranbaxy Lab Ltd Process for the preparation of amorphous cilastatin sodium
AR036018A1 (es) * 2001-05-18 2004-08-04 Ranbaxy Lab Ltd Proceso para aislar monohidrato de imipenem cristalino puro
PT1395587E (pt) * 2001-05-18 2009-09-03 Ranbaxy Lab Ltd Processo para a preparação de imipenem
EP1426376A4 (en) * 2001-08-13 2004-12-22 Eisai Co Ltd PROCESS FOR THE PREPARATION OF CARBAPENEM-BASED ANTIBIOTICS
BR0214209A (pt) 2001-11-16 2004-10-26 Ranbaxy Lab Ltd Processo para a preparação de imipenem cristalino e composto preparado pelo dito processo
US6537985B1 (en) 2001-11-30 2003-03-25 Phoenix Scientific, Inc. Antibiotic formulation and a method of making this formulation
JP4500814B2 (ja) * 2003-12-09 2010-07-14 チョンウェ ファーマ コーポレーション イミペネム（ｉｍｉｐｅｎｅｍ）の新規な製造方法
KR100848751B1 (ko) * 2006-11-10 2008-07-25 제일약품주식회사 이미페넴의 제조방법
KR100848752B1 (ko) * 2006-11-10 2008-07-25 제일약품주식회사 티에나마이신 용매화합물 및 그의 제조방법
EP2209787A4 (en) * 2007-10-08 2011-08-03 Orchid Chemicals & Pharm Ltd METHOD FOR PRODUCING A CARBAPENEM ANTIBIOTICS
CN108623598A (zh) * 2018-05-21 2018-10-09 重庆天地药业有限责任公司 一种亚胺培南中间体及亚胺培南的制备方法
CN111413427A (zh) * 2020-04-08 2020-07-14 苏州和合医学检验有限公司 超滤前处理高效液相色谱测定血浆中亚胺培南含量的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194047A (en) 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
US4260543A (en) 1978-07-03 1981-04-07 Merck & Co., Inc. Crystalline N-formimidoyl thienamycin
JP3048196B2 (ja) 1991-06-20 2000-06-05 第一製薬株式会社 カルバペネム誘導体
CZ73194A3 (en) 1991-10-01 1994-11-16 Procter & Gamble Pharma Process for preparing anti-microbial quinolonyl-lactams
CA2105746A1 (en) 1992-09-09 1994-03-10 Akira Yoshida Process for preparing carbapenem and penem compounds and new compounds involved in that process
US5245069A (en) * 1992-10-27 1993-09-14 Merck & Co., Inc. Process for the preparation of bis(aryl)-phosphorohalidates
US5872250A (en) 1997-07-30 1999-02-16 Merck & Co., Inc. Process for synthesizing carbapenem antibiotics

Also Published As

Publication number Publication date
ATE322495T1 (de) 2006-04-15
KR20030059812A (ko) 2003-07-10
US20040054167A1 (en) 2004-03-18
EE200300206A (et) 2003-10-15
US7078534B2 (en) 2006-07-18
EA006442B1 (ru) 2005-12-29
CA2427762C (en) 2009-10-20
ZA200303338B (en) 2004-03-09
MXPA03003916A (es) 2004-01-29
DE60118593D1 (de) 2006-05-18
EA200300520A1 (ru) 2003-10-30
IN191798B (enExample) 2004-01-03
EP1334105B1 (en) 2006-04-05
PT1334105E (pt) 2006-08-31
CA2427762A1 (en) 2002-05-10
JP2004525084A (ja) 2004-08-19
CN100445284C (zh) 2008-12-24
CN1481384A (zh) 2004-03-10
AU2002212591A1 (en) 2002-05-15
WO2002036594A1 (en) 2002-05-10
ES2261494T3 (es) 2006-11-16
BG107852A (bg) 2004-01-30
EP1334105A1 (en) 2003-08-13

Similar Documents

Publication Publication Date Title
DE60209348D1 (de) Dipeptidylpeptidase-hemmer zur behandlung von diabetes
HUP0400446A2 (hu) Azitromicin kristályformái
MXPA05013752A (es) Procedimiento e intermediarios para la preparacion de (1r,2s,5s)-6,6-dimetil-3-azabiciclo[3,1,0]exan-2-carboxilatos o sales de los mismos.
DE60224189D1 (de) Dipeptidylpeptidase-hemmer zur behandlung von diabetes
YU42803A (sh) Novi kristalni oblici atorvastatin hemi-kalcijuma i postupci za njihovo pripremanje kao i novi postupci za pripremanje drugih oblika
AU2003297291A1 (en) Substituted arylcyclopropylacetamides as glucokinase activators
WO2004062613A3 (en) Hiv integrase inhibitors
MXPA04008613A (es) N-aminoacetil-pirrolidina-2-carbonitrilos y su uso como inhibidores de ddp-iv.
MY142423A (en) Substituted aminoacetyl pyrrolidine compounds which are dipeptidyl peptidase iv inhibitors, and pharmaceutical compositions containing them
UA81567C2 (en) Heteroaroyl-substituted phenylalanine amides
EE200300206A (et) Kristalse N-formimidoüültienamütsiinmonohüdraadi (imipeneemmonohüdraadi) valmistamise meetod
MXPA05010433A (es) Derivados de pirrolidina y procedimiento para prepararlos.
EA200200510A1 (ru) 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр
MXPA04004604A (es) Proceso para la preparacion de imipenem cristalino.
WO2006113509A3 (en) Quinobenzoxazine analogs and methods of using thereof
WO2004091504A3 (en) Substituted quinobenzoxazine analogs
BR0307595A (pt) Uso de inibidores de pde5 tal como sildenafil no tratamento de sìndrome de ovário policìstico
MXPA05009688A (es) Derivados de naftiridina como agentes antibacterianos.
ZA200800138B (en) Process for the preparation of crystalline perindopril
NO20005301L (no) Pyrrolidiner som inhibitorer av neuraminidaser
DK1206452T3 (da) Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser
PT1165485E (pt) Processo para a preparacao de produtos intermediarios pesticidas
MXPA03010498A (es) Proceso para la preparacion de imipenem.
PL373527A1 (en) Process for the isolation of crystalline imipenem
MY134151A (en) Process for the preparation of crystalline n-formimindoyl thienamycin monohydrate (imipenem monohydrate)